메뉴 건너뛰기




Volumn 71, Issue 12, 2016, Pages 1137-1144

Persistence of circulating endothelial microparticles in COPD despite smoking cessation

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOPROTEIN IB ALPHA;

EID: 85002931061     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-208274     Document Type: Article
Times cited : (41)

References (42)
  • 2
    • 0017402583 scopus 로고
    • The natural history of chronic airflow obstruction
    • Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-8
    • (1977) Br Med J , vol.1 , pp. 1645-1648
    • Fletcher, C.1    Peto, R.2
  • 3
    • 84862833566 scopus 로고    scopus 로고
    • Small-airway obstruction and emphysema in chronic obstructive pulmonary disease
    • McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-75
    • (2011) N Engl J Med , vol.365 , pp. 1567-1575
    • McDonough, J.E.1    Yuan, R.2    Suzuki, M.3
  • 4
    • 0036729605 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease-part 2: Pathology and biochemistry of emphysema
    • Hogg JC, Senior RM. Chronic obstructive pulmonary disease-part 2: pathology and biochemistry of emphysema. Thorax 2002; 57: 830-4
    • (2002) Thorax , vol.57 , pp. 830-834
    • Hogg, J.C.1    Senior, R.M.2
  • 5
    • 10644266789 scopus 로고    scopus 로고
    • Mediators of chronic obstructive pulmonary disease
    • Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515-48
    • (2004) Pharmacol Rev , vol.56 , pp. 515-548
    • Barnes, P.J.1
  • 7
    • 0035744613 scopus 로고    scopus 로고
    • Disease of the airways in chronic obstructive pulmonary disease
    • Cosio Piqueras MG, Cosio MG. Disease of the airways in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34: 41s-9s
    • (2001) Eur Respir J Suppl , vol.34 , pp. 41s-49s
    • Cosio Piqueras, M.G.1    Cosio, M.G.2
  • 8
    • 4344675455 scopus 로고    scopus 로고
    • Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
    • Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-21
    • (2004) Lancet , vol.364 , pp. 709-721
    • Hogg, J.C.1
  • 9
    • 0038070219 scopus 로고    scopus 로고
    • Alveolar wall apoptosis causes lung destruction and emphysematous changes
    • Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003; 28: 555-62
    • (2003) Am J Respir Cell Mol Biol , vol.28 , pp. 555-562
    • Aoshiba, K.1    Yokohori, N.2    Nagai, A.3
  • 11
    • 79952336653 scopus 로고    scopus 로고
    • Pathogenesis of chronic obstructive pulmonary disease
    • Rennard SI. Pathogenesis of chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2011; 79: 132-8
    • (2011) Pneumonol Alergol Pol , vol.79 , pp. 132-138
    • Rennard, S.I.1
  • 12
    • 80051565223 scopus 로고    scopus 로고
    • Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers
    • Gordon C, Gudi K, Krause A, et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011; 184: 224-32
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 224-232
    • Gordon, C.1    Gudi, K.2    Krause, A.3
  • 13
    • 0034988243 scopus 로고    scopus 로고
    • Lung uptake of antibodies to endothelial antigens: Key determinants of vascular immunotargeting
    • Danilov SM, Gavrilyuk VD, Franke FE, et al. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1335-47
    • (2001) Am J Physiol Lung Cell Mol Physiol , vol.280 , pp. L1335-L1347
    • Danilov, S.M.1    Gavrilyuk, V.D.2    Franke, F.E.3
  • 14
    • 80051559745 scopus 로고    scopus 로고
    • Endothelial chronic destructive pulmonary disease (E-CDPD is endothelial apoptosis a subphenotype or prequel to COPD?
    • Chandra D, Sciurba FC, Gladwin MT. Endothelial chronic destructive pulmonary disease (E-CDPD): is endothelial apoptosis a subphenotype or prequel to COPD? Am J Respir Crit Care Med 2011; 184: 153-5
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 153-155
    • Chandra, D.1    Sciurba, F.C.2    Gladwin, M.T.3
  • 15
    • 0034063821 scopus 로고    scopus 로고
    • Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease the lung health study
    • Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-90
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 381-390
    • Scanlon, P.D.1    Connett, J.E.2    Waller, L.A.3
  • 17
    • 80053586178 scopus 로고    scopus 로고
    • Pilot analysis of the plasma metabolite profiles associated with emphysematous chronic obstructive pulmonary disease phenotype
    • Paige M, Burdick MD, Kim S, et al. Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Biochem Biophys Res Commun 2011; 413: 588-93
    • (2011) Biochem Biophys Res Commun , vol.413 , pp. 588-593
    • Paige, M.1    Burdick, M.D.2    Kim, S.3
  • 18
    • 78650214523 scopus 로고    scopus 로고
    • Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke
    • Strulovici-Barel Y, Omberg L, O?Mahony M, et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med 2010; 182: 1524-32
    • (2010) Am J Respir Crit Care Med , vol.182 , pp. 1524-1532
    • Strulovici-Barel, Y.1    Omberg, L.2    O'Mahony, M.3
  • 19
    • 21044438176 scopus 로고    scopus 로고
    • Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease
    • Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-30
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1622-1630
    • Koga, H.1    Sugiyama, S.2    Kugiyama, K.3
  • 20
    • 33847610302 scopus 로고    scopus 로고
    • Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes
    • Tushuizen ME, Nieuwland R, Rustemeijer C, et al. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 2007; 30: 728-30
    • (2007) Diabetes Care , vol.30 , pp. 728-730
    • Tushuizen, M.E.1    Nieuwland, R.2    Rustemeijer, C.3
  • 21
    • 0037315391 scopus 로고    scopus 로고
    • Effects of severe hypertension on endothelial and platelet microparticles
    • Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-17
    • (2003) Hypertension , vol.41 , pp. 211-217
    • Preston, R.A.1    Jy, W.2    Jimenez, J.J.3
  • 22
    • 0035840849 scopus 로고    scopus 로고
    • Oxidative stress and lung inflammation in airways disease
    • MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429: 195-207
    • (2001) Eur J Pharmacol , vol.429 , pp. 195-207
    • MacNee, W.1
  • 23
    • 41949115834 scopus 로고    scopus 로고
    • Pathogenesis of COPD part i the role of protease-antiprotease imbalance in emphysema
    • Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 2008; 12: 361-7
    • (2008) Int J Tuberc Lung Dis , vol.12 , pp. 361-367
    • Abboud, R.T.1    Vimalanathan, S.2
  • 24
    • 2442661930 scopus 로고    scopus 로고
    • Endothelial microparticles as markers of endothelial dysfunction
    • Horstman LL, Jy W, Jimenez JJ, et al. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-35
    • (2004) Front Biosci , vol.9 , pp. 1118-1135
    • Horstman, L.L.1    Jy, W.2    Jimenez, J.J.3
  • 25
    • 0037709857 scopus 로고    scopus 로고
    • Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis
    • Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80
    • (2003) Thromb Res , vol.109 , pp. 175-180
    • Jimenez, J.J.1    Jy, W.2    Mauro, L.M.3
  • 26
    • 33644831131 scopus 로고    scopus 로고
    • Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease
    • Werner N, Wassmann S, Ahlers P, et al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112-16
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 112-116
    • Werner, N.1    Wassmann, S.2    Ahlers, P.3
  • 27
    • 0033999142 scopus 로고    scopus 로고
    • Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
    • Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3
    • (2000) Circulation , vol.101 , pp. 841-843
    • Mallat, Z.1    Benamer, H.2    Hugel, B.3
  • 28
    • 33646812544 scopus 로고    scopus 로고
    • Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome
    • Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006; 4: 1296-302
    • (2006) J Thromb Haemost , vol.4 , pp. 1296-1302
    • Simak, J.1    Gelderman, M.P.2    Yu, H.3
  • 29
    • 33644876174 scopus 로고    scopus 로고
    • Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure
    • Amabile N, Guérin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-8
    • (2005) J Am Soc Nephrol , vol.16 , pp. 3381-3388
    • Amabile, N.1    Guérin, A.P.2    Leroyer, A.3
  • 30
    • 7044271283 scopus 로고    scopus 로고
    • Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension
    • González-Quintero VH, Smarkusky LP, Jiménez JJ, et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol 2004; 191: 1418-24
    • (2004) Am J Obstet Gynecol , vol.191 , pp. 1418-1424
    • González-Quintero, V.H.1    Smarkusky, L.P.2    Jiménez, J.J.3
  • 31
    • 44449177817 scopus 로고    scopus 로고
    • Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
    • Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: 1268-75
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 1268-1275
    • Amabile, N.1    Heiss, C.2    Real, W.M.3
  • 32
    • 33745168947 scopus 로고    scopus 로고
    • Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome
    • Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006; 98: 70-4
    • (2006) Am J Cardiol , vol.98 , pp. 70-74
    • Arteaga, R.B.1    Chirinos, J.A.2    Soriano, A.O.3
  • 33
    • 20944438125 scopus 로고    scopus 로고
    • Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism
    • Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45: 1467-71
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1467-1471
    • Chirinos, J.A.1    Heresi, G.A.2    Velasquez, H.3
  • 34
    • 61649117010 scopus 로고    scopus 로고
    • Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
    • Ayers L, Ferry B, Craig S, et al. Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur Respir J 2009; 33: 574-80
    • (2009) Eur Respir J , vol.33 , pp. 574-580
    • Ayers, L.1    Ferry, B.2    Craig, S.3
  • 35
    • 42949090751 scopus 로고    scopus 로고
    • Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: Sustained vascular injury and blunted nitric oxide production
    • Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 2008; 51: 1760-71
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1760-1771
    • Heiss, C.1    Amabile, N.2    Lee, A.C.3
  • 36
    • 58849150305 scopus 로고    scopus 로고
    • Desmosine as a biomarker of elastin degradation in COPD: Current status and future directions
    • Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008; 32: 1146-57
    • (2008) Eur Respir J , vol.32 , pp. 1146-1157
    • Luisetti, M.1    Ma, S.2    Iadarola, P.3
  • 37
    • 70349632392 scopus 로고    scopus 로고
    • Biomarkers of lung damage associated with tobacco smoke in induced sputum
    • Comandini A, Rogliani P, Nunziata A, et al. Biomarkers of lung damage associated with tobacco smoke in induced sputum. Respir Med 2009; 103: 1592-613
    • (2009) Respir Med , vol.103 , pp. 1592-1613
    • Comandini, A.1    Rogliani, P.2    Nunziata, A.3
  • 38
    • 80053424584 scopus 로고    scopus 로고
    • The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema
    • Criner GJ, Cordova F, Sternberg AL, et al. The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med 2011; 184: 763-70
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 763-770
    • Criner, G.J.1    Cordova, F.2    Sternberg, A.L.3
  • 39
    • 80052690031 scopus 로고    scopus 로고
    • The chronic bronchitic phenotype of COPD: An analysis of the COPDGene Study
    • Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011; 140: 626-33
    • (2011) Chest , vol.140 , pp. 626-633
    • Kim, V.1    Han, M.K.2    Vance, G.B.3
  • 40
    • 84855280191 scopus 로고    scopus 로고
    • Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease
    • Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 44-52
    • (2012) Am J Respir Crit Care Med , vol.185 , pp. 44-52
    • Nishimura, M.1    Makita, H.2    Nagai, K.3
  • 41
    • 84856780025 scopus 로고    scopus 로고
    • Which pulmonary function tests best differentiate between COPD phenotypes?
    • Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care 2012; 57: 50-60
    • (2012) Respir Care , vol.57 , pp. 50-60
    • Salzman, S.H.1
  • 42
    • 80053534329 scopus 로고    scopus 로고
    • Avoiding confusion in COPD: From risk factors to phenotypes to measures of disease characterisation
    • Agustí A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J 2011; 38: 749-51
    • (2011) Eur Respir J , vol.38 , pp. 749-751
    • Agustí, A.1    Celli, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.